|

Single dose injection of certain dose of UWD-00B Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Wondercel Biotech (ShenZhen)1

Indications

  • Refractory and Relapsed Multiple Myeloma1
  • Multiple Myleoma1
  • Cancer1

Other1 trial

Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.